- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04017117
Augmentation of Atrophic Mandibule Using Poly Ether Ether Ketone Mesh (RCT)
Comparative Study Between Custom-made Polyether Ether Ketone and Titanium Mesh for Augmentation of Atrophic Posterior Mandible. Randomized Clinical Trial
Study Overview
Status
Conditions
Detailed Description
Designing and manufacturing
1. The CBCT images of the patient will be used to build a digital model using a 3D planning software (Mimics innovation suite). Based on this model, a machine will be used to mill a pressed and pre-sintered body of PEEK to the desired macroscopic shape.
2. The size of the machined sheet is enlarged in order to compensate for the sintering shrinkage performed at 1450 C.
3. After manufacturing, the sheet will be cleaned in an ultrasonic bath of 70% alcohol for 15 min, followed by a brief heating to 1200 C.
4. It will be again cleaned in an ultrasonic bath for 3x15 min using 90% alcohol.
5. Thereafter the sheet was placed in an autoclave and sterilized using a standard program.
6. The sheets will have a thickness of approximately 0.5 - 0.7 mm. b. Surgery
- The intraoral area is initially cleaned with chlorhexidine 1 mg/ml.
- Local anesthesia is administered.
- Horizontal crestal incisions are made lingual of the mid-crest within the keratinized tissue. Vertical releasing incisions are placed on the buccal aspect of the surgical site in the usual manner to provide adequate access and to allow for eventual coronal repositioning.
- Then, a full-thickness mucoperiosteal flap is reflected to completely expose the atrophic ridge.
- The cortex of the mandibular crest is generously perforated to produce bleeding in multiple sites. The pilot holes for the fixation screws were also prepared at this time.
- The barrier is inserted over the mandible and compressed into place, the fixation screws are inserted and no adaptation will be needed as the barrier is custom-made for the edentulous ridge.
- The ceramic sheets is cleaned with 3% hydrogen peroxide prior to soft tissue closure.
- After fixation of the sheets, the buccal flaps should be coronally repositioned.
- Split-thickness periosteal releasing incisions are completed to aid in primary tension-free closure. The flap margins are then advanced over the barrier and approximated to evaluate for tension-free closure.
- After a mean of 6 months of uneventful healing, the augmented sites are reopened. The ceramic barrier and fixation screws are identified and removed, followed by Dental implant.
Post-operative care:
Avoid traumatization of the surgical site. Patients must abstain from brushing at the surgical area. Instead, a disinfecting mouth rinse should be used (e.g. chlorhexidine 0.2%).
Instruct the patient not to touch or manipulate the surgical area. Ice packs for 10 minutes every 30 minutes for 24 hours. Do not use removable dentures during the expansion phase. Temporary fixed partial dentures must be adjusted to the expected tissue gain.
No consume of tobacco
Post-operative medications will be prescribed as follows:
Amoxicillin/clavulanic acid tablets 10mg/kg every 12 hours for 7 days, diclofenac potassium 50mg every 8 hours for 4 days and then as needed, metronidazole 5 mg/kg every 8 hours for 7 days and chlorhexidine gluconate 0.1% mouthwash 3 times daily for 14 days.
11b. Criteria for discontinuing or modifying intervention: No protocol for discontinuation of the procedure. 11c. Strategies to improve adherence to intervention: Face to face adherence reminder session will take place to stress on the post-operative instructions at the following time intervals.
Patients were recalled every other day to monitor soft tissue healing for the first week, one visit weekly for the first month then monthly for 6 months.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Adham Y Zakaria, Master
- Phone Number: 00201226000564
- Email: amira_5queens@hotmail.com
Study Contact Backup
- Name: Adham Y Zakaria, Master
- Phone Number: 00201226000741
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Faculty Of Dental and Oral Medicine-Cairo University
-
Contact:
- Adham Y Zakaria, Master
- Phone Number: 00201226000564
- Email: amira_5queens@hotmail.com
-
Contact:
- Adham Y Zakaria, Master
- Phone Number: 00201226000741
- Email: amira_5queens@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with atrophic posterior mandible
- Both sexes
- No intraoral soft and hard tissue pathology
- No systemic condition that contraindicate implant placement
Exclusion Criteria:
- Untreated gingivitis, periodontitis
- Insufficient oral hygiene
- Previous radiation therapy the head and neck neoplasia, or bone augmentation to implant site.
- Systemic disorders
- Heavy smoking more than 20 cigarettes per day
- Bone pathology
- Psychiatric problems
- Emotional instability
- Unrealistic aesthetic demands
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Custom Made Poly Ether Ether Ketone Mesh
Applying Poly Ether Ether Ketone mesh with mix of autogenous bone graft and bone substitute in posterior atrophic mandible for augmentation
|
comparing between PEEK mesh and Titanium mesh for augmentation of posterior atrophic mandible using mix of autogenous bone graft and bone substitute.
|
Active Comparator: Conventional Titanium mesh
Applying Titanium mesh with mix of autogenous bone graft and bone substitute in posterior atrophic mandible for augmentation
|
comparing between PEEK mesh and Titanium mesh for augmentation of posterior atrophic mandible using mix of autogenous bone graft and bone substitute.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vertical amount of bone increased (length in millimeters). horizontal amount f bone increased after augmentation (width in millimeters).
Time Frame: 6 months
|
Length (Vertical Augmentation) Width (horizontal augmentation) gained after augmentation of atrophic mandible in millimeters using cone beam computed tomography (measuring tool) measurment tools : with the aid of cone beam computed tomography
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Soft Tissue Dehiscence
Time Frame: 6 months
|
which mesh will cause soft tissue dehiscence more.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Mohamed F Shehab, PHD, Professor of Oral and Maxillofacial Surgery - Cairo University.
- Study Director: Khaled A Salaheddin, PHD, Lecturer of Oral and Maxillofacial Surgery - Cairo University.
Publications and helpful links
General Publications
- Misch CM. Bone augmentation of the atrophic posterior mandible for dental implants using rhBMP-2 and titanium mesh: clinical technique and early results. Int J Periodontics Restorative Dent. 2011 Nov-Dec;31(6):581-9.
- Her S, Kang T, Fien MJ. Titanium mesh as an alternative to a membrane for ridge augmentation. J Oral Maxillofac Surg. 2012 Apr;70(4):803-10. doi: 10.1016/j.joms.2011.11.017. Epub 2012 Jan 28.
- Pieri F, Corinaldesi G, Fini M, Aldini NN, Giardino R, Marchetti C. Alveolar ridge augmentation with titanium mesh and a combination of autogenous bone and anorganic bovine bone: a 2-year prospective study. J Periodontol. 2008 Nov;79(11):2093-103. doi: 10.1902/jop.2008.080061.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEBD-CU-2019-06-19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mandible Small
-
Cairo UniversityActive, not recruitingVertical Deficeny of Posterior MandibleEgypt
-
University of LiegeCompletedPatients Requiring Mandible Orthodontic TreatmentBelgium
-
Nantes University HospitalCompletedOsteoradionecrosis | MandibleFrance
-
Tanta UniversityCompletedMandibular Diseases | Mandible Tumor | Mandible CystEgypt
-
Hams Hamed AbdelrahmanCompleted
-
University of Medicine and Pharmacy at Ho Chi Minh...RecruitingBenign Neoplasm | Mandible | Virtual Surgical PlanningVietnam
-
Boston Medical CenterWithdrawnFree Tissue Transfer | Mandible Reconstruction | Computerized CustomizationUnited States
-
University Hospital, MontpellierCompletedMandibular Asymmetry | Functional Shift of the MandibleFrance
-
Cairo UniversityUnknownPosterior Mandible With Deficient Ridge Height
-
Cairo UniversityRecruiting